Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma (NCT01334008) | Clinical Trial Compass
CompletedNot Applicable
Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma
France40 participantsStarted 2011-04
Plain-language summary
Circulating tumor DNA detection and quantification in patients with metastatic choroidal melanoma.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age \> or = 18 years.
* Patient with a metastatic choroidal melanoma.
* Patient with tumor or metastasis available for GNAQ (Guanine nucleotide blinding protein) status characterization.
* Patient able to stand a blood collection.
* Signed written informed consent approved by competent authority and ethic committee.
Exclusion Criteria:
* Patient without social protection/insurance.
* Current pregnancy and lactation.
* All social, medical, psychological, situations making the study impossible.
* Person deprived of liberty.
What they're measuring
1
Assessment and development of circulating tumor DNA detection techniques